Laerdal Medical Corporation

Laerdal Medical Corporation, doing business as Laerdal Medical Corp, manufactures and sells high-fidelity patient simulators, manikins, airway management trainers, and related medical training equipment to the federal government as a prime contractor, competing full-and-open without set-aside designations across a diversified portfolio of 1,322 federal awards spanning four decades.

Based in Wappingers Falls, New York, Laerdal Medical is a for-profit manufacturer classified under NAICS codes spanning plastics product manufacturing, surgical instrument manufacturing, and medical equipment wholesale. The company operates predominantly as a prime contractor (100% of the award footprint in the source data), with a single subcontract reference under Atlantic Diving Supply for a Joint Program Executive Office Chemical, Biological, Radiological, Nuclear Defense medical equipment sub-award in July 2024.

Laerdal's federal capability portfolio centers on medical simulation equipment and sustainment services. Representative prime work includes a $2.39 million firm fixed-price delivery order from the Department of the Army's PEO Simulation, Training and Instrumentation (STRI) for high-fidelity patient simulation equipment (June 2022); a $3.17 million firm fixed-price delivery order from Army PEO STRI for simulation requirements (April 2022); and an $842 thousand Foreign Military Sales definitive contract from the Army Materiel Command for SIMMAN 3G manikins with accessories and airway management trainers (April 2022). Recent work includes a $216 thousand purchase order from Veterans Integrated Service Network 8 for simulation equipment delivery to Miami, Florida (September 2026), a $176 thousand five-year SimCapture cloud subscription from VISN 4 (September 2026), and maintenance and warranty contracts with the Air Force, Defense Health Agency, and multiple VA medical centers.

Customer concentration is heavily weighted to Army medical training and simulation infrastructure. The top five customers by combined potential value account for 95% of dollars: the Department of the Army Medical Command anchors the portfolio at 64 awards worth $193.5 million combined potential value, followed by Army PEO STRI at 16 awards worth $30.2 million, VISN 4 at 20 awards worth $2.2 million, the Defense Health Agency at 28 awards worth $1.9 million, and the Department of the Navy Bureau of Medicine and Surgery at 51 awards worth $929 thousand. By award count, the concentration is lighter — the top five customers account for 16% of awards — reflecting Laerdal's deep penetration of distributed VA medical center procurement (multiple VISN networks) and Navy medical facility orders.

Laerdal sits on multiple General Services Administration Federal Supply Schedules (GS02F5656A with 11 task orders, GS02F9315C with 5 task orders, GS02F9380C with 4 task orders) and on an indefinite delivery contract (W900KK18D0013) with 3 task orders and $7.5 million combined potential value. These vehicles enable task-order procurement across federal medical facilities without individual contract awards.

Activity has contracted in recent years: the portfolio delivered 13 awards in 2022, declining to 12 in 2024, 3 in 2025, and 8 through September 2026. Over 1,322 awards, combined potential value totals $242 million with $54.6 million obligated to date (23% funding rate). Only four awards face ultimate completion within the next twenty-four months, carrying combined potential value of $376 thousand, indicating minimal recompete cliff exposure in the near term. The supplier base is highly stable, with awards spanning 116 distinct customer agencies and extending back to 1980, anchored by direct federal procurement relationships with Army medical schools, VA medical centers, and Defense Health Agency facilities rather than by large consolidated IDIQs or GWACs.